CHI3L1 and idiopathic pulmonary fibrosis: In the first year of antifibrotic therapy, no significant correlations between longitudinal changes in serum CHIT1 activity and YKL-40 concentration and longitudinal changes in FVC% pred., TL,CO% pred., and 6MWT distance were observed in any of the subgroups of IPF patients.